- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07844369
Patient Safety Competency-Building Program for Healthcare Professionals in Pediatric Cardiac Critical Care in Ethiopia
Development and Evaluation of a Patient Safety Competency-Building Program for Healthcare Professionals in Pediatric Cardiac Critical Care in Ethiopia
This study aims to develop and evaluate a patient safety competency-building program for healthcare professionals involved in pediatric cardiac critical care in Ethiopia. The program consists of educational modules addressing key areas of patient safety and is delivered in person at a tertiary hospital in Addis Ababa, Ethiopia. Patient safety competence is assessed before and immediately after each training round, and acceptability, appropriateness, and feasibility are assessed immediately after each training round as implementation outcomes.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
The patient safety competency-building program comprises nine educational modules delivered across three training rounds, with selected modules provided during each round. Healthcare professionals involved in pediatric cardiac critical care may participate in one or more training rounds, and participants may therefore differ across rounds. For each training round, patient safety competence is assessed before the training and immediately after its completion as a common educational outcome. Medication safety competence is assessed before and immediately after the first training round as a round-specific educational outcome. Acceptability, appropriateness, and feasibility are assessed immediately after each training round as implementation outcomes.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Addis Ababa
-
Addis Ababa, Addis Ababa, Etiopia
- Tikur Anbessa Specialized Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Healthcare professionals involved in pediatric cardiac critical care at Tikur Anbessa Specialized Hospital, including physicians, nurses, perfusionists, and other relevant healthcare professionals
- Able to understand the purpose and procedures of the study and voluntarily provide informed consent
Exclusion Criteria:
- Healthcare professionals who are on leave or are not directly involved in pediatric cardiac critical care at the time of the study
- Individuals who are unable to adequately understand or participate in the educational program conducted in English, even with Amharic language support
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Patient Safety Competency-Building Program
Participants receive a patient safety competency-building program designed for healthcare professionals involved in pediatric cardiac critical care. The program comprises nine educational modules and is delivered in person across three training rounds, with selected patient safety modules provided during each round. |
The patient safety competency-building program consists of nine educational modules: Patient Safety Principles; Teamwork and Communication; Surgical Safety; Medication Safety; Blood Transfusion Safety; Infection Control; Patient Assessment and Clinical Decision-Making; Safety Equipment Management; and Patient Safety Incident Response and Reporting. Selected modules are delivered during each training round through in-person lectures, group discussions, and practical activities. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Patient Safety Competence
Tidsramme: Before and immediately after each training round
|
Patient safety competence is measured using the Health Professional Education in Patient Safety Survey (H-PEPSS), a 16-item self-report instrument covering six domains: working in teams with other health professionals, communicating effectively, managing safety risks, understanding human and environmental factors, recognizing and responding to adverse events, and culture of safety. Scores are calculated as the mean of the 16 items, with possible scores ranging from 1 to 5; higher scores indicate greater perceived patient safety competence. |
Before and immediately after each training round
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Medication Safety Competence
Tidsramme: Before and immediately after the first training round
|
Medication safety competence is measured using the Medication Safety Competence Scale (MSCS), a 36-item self-report instrument covering six domains: patient-centered medication management, improvement of safety problems, management of effecting factors, safety risk management, multidisciplinary collaboration, and responsibility in the nursing profession. Scores are calculated as the mean of the 36 items, with possible scores ranging from 1 to 5; higher scores indicate greater medication safety competence. |
Before and immediately after the first training round
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Acceptability of the Intervention
Tidsramme: Immediately after each training round
|
Acceptability is measured using the Acceptability of Intervention Measure (AIM). The AIM consists of four items rated on a 5-point Likert scale. Scores are calculated as the mean of the four items, ranging from 1 to 5; higher scores indicate greater acceptability of the intervention. |
Immediately after each training round
|
|
Appropriateness of the Intervention
Tidsramme: Immediately after each training round
|
Appropriateness is measured using the Intervention Appropriateness Measure (IAM). The IAM consists of four items rated on a 5-point Likert scale. Scores are calculated as the mean of the four items, ranging from 1 to 5; higher scores indicate greater perceived appropriateness of the intervention. |
Immediately after each training round
|
|
Feasibility of the Intervention
Tidsramme: Immediately after each training round
|
Feasibility is measured using the Feasibility of Intervention Measure (FIM). The FIM consists of four items rated on a 5-point Likert scale. Scores are calculated as the mean of the four items, ranging from 1 to 5; higher scores indicate greater perceived feasibility of the intervention. |
Immediately after each training round
|
|
Program Satisfaction
Tidsramme: Immediately after each training round
|
Program satisfaction is assessed using a questionnaire developed by the research team. The questionnaire includes 5-point ratings of overall satisfaction, individual educational sessions, and five aspects of the educational experience, as well as a 10-point rating of achievement of the program objectives. Higher scores indicate more favorable evaluations. Open-ended questions are included to obtain additional participant feedback. |
Immediately after each training round
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Woong-Han Kim, MD, PhD, Seoul National University Hospital
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- H-2607-045-1764
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .